Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;6(5):487-494.
doi: 10.3892/br.2017.892. Epub 2017 Apr 12.

Renal manifestations of primary mitochondrial disorders

Affiliations

Renal manifestations of primary mitochondrial disorders

Josef Finsterer et al. Biomed Rep. 2017 May.

Abstract

The aim of the present review was to summarize and discuss previous findings concerning renal manifestations of primary mitochondrial disorders (MIDs). A literature review was performed using frequently used databases. The study identified that primary MIDs frequently present as mitochondrial multiorgan disorder syndrome (MIMODS) at onset or in the later course of the MID. Occasionally, the kidneys are affected in MIDs. Renal manifestations of MIDs include renal insufficiency, nephrolithiasis, nephrotic syndrome, renal cysts, renal tubular acidosis, Bartter-like syndrome, Fanconi syndrome, focal segmental glomerulosclerosis, tubulointerstitial nephritis, nephrocalcinosis, and benign or malign neoplasms. Among the syndromic MIDs, renal involvement has been most frequently reported in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome, Kearns-Sayre syndrome, Leigh syndrome and mitochondrial depletion syndromes. Only in single cases was renal involvement also reported in chronic progressive external ophthalmoplegia, Pearson syndrome, Leber's hereditary optic neuropathy, coenzyme-Q deficiency, X-linked sideroblastic anemia and ataxia, myopathy, lactic acidosis, and sideroblastic anemia, pyruvate dehydrogenase deficiency, growth retardation, aminoaciduria, cholestasis, iron overload, lactacidosis, and early death, and hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis syndrome. The present study proposes that the frequency of renal involvement in MIDs is probably underestimated. Diagnosis of renal involvement follows general guidelines and treatment is symptomatic. Thus, renal manifestations of primary MIDs require recognition and appropriate management, as they determine the outcome of MID patients.

Keywords: mtDNA mutation; oxidative phosphorylation; renal dysfunction; renal tubular acidosis; respiratory chain.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Finsterer J. Inherited mitochondrial disorders. Adv Exp Med Biol. 2012;942:187–213. doi: 10.1007/978-94-007-2869-1_8. - DOI - PubMed
    1. McFarland R, Taylor RW, Turnbull DM. A neurological perspective on mitochondrial disease. Lancet Neurol. 2010;9:829–840. doi: 10.1016/S1474-4422(10)70116-2. - DOI - PubMed
    1. Finsterer J, Zarrouk-Mahjoub S. Mitochondrial Disorders May Mimic Amyotrophic Lateral Sclerosis at Onset. Sultan Qaboos Univ Med J. 2016;16:e92–e95. doi: 10.18295/squmj.2016.16.01.017. - DOI - PMC - PubMed
    1. Emma F, Montini G, Parikh SM, Salviati L. Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat Rev Nephrol. 2016;12:267–280. doi: 10.1038/nrneph.2015.214. - DOI - PMC - PubMed
    1. Niaudet P. Renal involvement in mitochondrial cytopathies. Nephrol Ther. 2013;9:116–124. doi: 10.1016/j.nephro.2012.10.004. (In French) - DOI - PubMed